Minnesota 2025-2026 Regular Session

Minnesota Senate Bill SF1877 Latest Draft

Bill / Engrossed Version Filed 03/13/2025

                            1.1	A bill for an act​
1.2 relating to health; requiring pharmacy benefit managers and health carriers to use​
1.3 prescription drug rebates and other compensation to benefit covered persons;​
1.4 requiring a report; proposing coding for new law in Minnesota Statutes, chapter​
1.5 62W.​
1.6BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:​
1.7 Section 1. [62W.16] RESPONSIBILITY TO USE COMPENSATION FOR BENEFIT​
1.8OF COVERED PERSONS.​
1.9 Subdivision 1.Compensation used to reduce point-of-sale costs.(a) Except as provided​
1.10in paragraph (b), a pharmacy benefit manager or health carrier must remit all compensation​
1.11received from a drug manufacturer related to its prescription drug benefit directly to the​
1.12covered person associated with a particular prescription drug, at the point of sale, to reduce​
1.13the covered person's out-of-pocket cost for that prescription drug.​
1.14 (b) A pharmacy benefit manager or health carrier is not required to remit all compensation​
1.15as required by paragraph (a), if the covered person's cost-sharing obligation for a particular​
1.16drug is less than what the person's out-of-pocket cost for that drug would be after application​
1.17of paragraph (a). All compensation retained by the pharmacy benefit manager or health​
1.18carrier under this paragraph must be applied by that entity in its plan design to offset future​
1.19premiums or costs for covered persons.​
1.20 (c) State employee group insurance program contracts with pharmacy benefit managers,​
1.21including but not limited to contracts under section 43A.231, must require pharmacy benefit​
1.22manager compliance with this section.​
1.23 Subd. 2.Definitions.(a) For purposes of this section, the following definitions apply.​
1​Section 1.​
S1877-1 1st Engrossment​SF1877 REVISOR SGS​
SENATE​
STATE OF MINNESOTA​
S.F. No. 1877​NINETY-FOURTH SESSION​
(SENATE AUTHORS: MANN)​
OFFICIAL STATUS​D-PG​DATE​
Introduction and first reading​552​02/27/2025​
Referred to Commerce and Consumer Protection​
Comm report: To pass as amended and re-refer to Health and Human Services​03/13/2025​ 2.1 (b) "Compensation" means any direct or indirect financial benefit, including but not​
2.2limited to rebates, discounts, credits, fees, grants, chargebacks, or other payments or benefits​
2.3of any kind.​
2.4 (c) "Cost-sharing obligation" means a covered person's co-payment or coinsurance for​
2.5a particular prescription drug.​
2.6 Subd. 3.Report on compliance.Beginning March 1, 2026, and each March 1 thereafter,​
2.7a pharmacy benefit manager or health carrier shall file with the commissioner a report, in​
2.8the form and manner specified by the commissioner, demonstrating how the pharmacy​
2.9benefit manager or health carrier has complied with this section.​
2.10 Subd. 4.Exception.This section does not apply to a pharmacy benefit manager or health​
2.11carrier if the covered person's cost-sharing obligation is equal to or less than:​
2.12 (1) $25 for a generic drug; and​
2.13 (2) $55 for a brand name drug.​
2.14 EFFECTIVE DATE.This section is effective January 1, 2026.​
2​Section 1.​
S1877-1 1st Engrossment​SF1877 REVISOR SGS​